Affordable Access

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

Authors
  • Romashkova, J A1
  • Makarov, S S
  • 1 Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, 27599-7280, USA.
Type
Published Article
Journal
Nature
Publication Date
Sep 02, 1999
Volume
401
Issue
6748
Pages
86–90
Identifiers
PMID: 10485711
Source
Medline
License
Unknown

Abstract

The mechanisms of cell proliferation and transformation are intrinsically linked to the process of apoptosis: the default of proliferating cells is to die unless specific survival signals are provided. Platelet-derived growth factor (PDGF) is a principal survival factor that inhibits apoptosis and promotes proliferation, but the mechanisms mediating its anti-apoptotic properties are not completely understood. Here we show that the transcription factor NF-kappaB is important in PDGF signalling. NF-kappaB transmits two signals: one is required for the induction of proto-oncogene c-myc and proliferation, and the second, an anti-apoptotic signal, counterbalances c-Myc cytotoxicity. We have traced a putative pathway whereby PDGF activates NF-kappaB through Ras and phospatidylinositol-3-kinase (PI(3)K) to the PKB/Akt protein kinase and the IkappaB kinase (IKK); NF-kappaB thus appears to be a target of the anti-apoptotic Ras/PI(3)K/Akt pathway. We show that, upon PDGF stimulation, Akt transiently associates in vivo with IKK and induces IKK activation. These findings establish a role for NF-kappaB in growth factor signalling and define an anti-apoptotic Ras/PI(3)K/Akt/IKK/NF-kappaB pathway, thus linking anti-apoptotic signalling with transcription machinery.

Report this publication

Statistics

Seen <100 times